The vision of precision oncology entails a shift toward (semi)automated, data-driven workflows that guide treatment on the basis of an individual patient's clinical and molecular profile and leverage ...

The federal government has backed off a proposal that would have let Medicare Part D prescription drug plans deny coverage for therapies in six "protected" classes of drugs, including those for cancer ...

Drug classes such as alpha-1 blockers, atypical antipsychotics, and tricyclic antidepressants were associated with an increased incidence of intraoperative floppy iris syndrome (IFIS), with imipramine ...

Drugs for inflammatory conditions drove nearly half of spending in commercial plans last year, a new report shows. Express Scripts released its annual Drug Trend Report, which analyzes costs and ...

Health Affairs' Senior Deputy Editor Rob Lott interviews Jihye Han of Brigham and Women's Hospital and Harvard University on her recent paper that takes a closer look at the regulatory treatments for ...

Credit: Getty Images In an unexpected finding, phosphodiesterase inhibitors and sympathomimetics with α- and β-effect were strongly associated with higher AKI risk in this analysis. High AKI risk was ...

The FDA’s recent complete response letter (CRL) for vadadustat — an oral therapy evaluated for the treatment of anemia in patients with chronic kidney disease (CKD) — was a big surprise and ...

Scientists have identified two molecules that could help treat leukemia, in a way that’s far less damaging to healthy cells than existing chemotherapy. The compounds work using a different mechanism ...

This story was originally published on Nov. 9, 2023 and has been updated to include an episode on the topic from Life Kit. College sophomore Elias Myers thinks his friends are lucky to be alive. The ...